June 18, 2021
Business News

Spruce Biosciences to Participate in the RBC Capital Markets Global Healthcare Conference

SAN FRANCISCO–()–Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that Richard King, Chief Executive Officer, will participate in a virtual fireside chat at the RBC Capital Markets Global Healthcare Conference on May 19, 2021 at 5:25pm EDT.

Interested parties can access the live webcast for the conference from the Events section of the company’s investor relations website at https://investors.sprucebiosciences.com. An archived replay of the webcast will be available after the conclusion of the live presentation for approximately 30…

Click here to view the original article.

Related Posts

You might also like ...

Dan Stahlschmidt Joins Academy Securities as Managing Director, Head of Equity Capital Markets
AON Splash Image
eCommerce Funding and Payments Leader Payability Hires VP of Growth Marketing
AON Splash Image
Arkema Announces a New Breakthrough Range of Renewable PVDF Grades for Lithium-Ion Batteries